Can a female patient’s pre‑existing rosacea lesion darken after receiving an iron infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Darkening of Rosacea After Iron Infusion: Not a Documented Association

While iron infusion can cause skin darkening through hemosiderin deposition at or near the infusion site, there is no established medical evidence linking iron infusions to darkening of pre-existing rosacea lesions. The darkening your patient is experiencing is more likely due to iron extravasation or post-inflammatory hyperpigmentation rather than a direct effect on the rosacea itself.

Understanding the Two Separate Issues

Iron-Related Skin Darkening

Iron infusions can cause cutaneous hemosiderosis (iron deposition in skin) through:

  • Direct extravasation at the infusion site, causing brownish hyperpigmentation that may be permanent 1, 2, 3
  • Diffuse staining in areas distant from the infusion site, particularly in patients with hyperhidrosis 4
  • This discoloration appears as light to dark brown staining and results from iron deposits in dermal tissues

Rosacea Characteristics

Rosacea presents with erythema, telangiectasia, papules, pustules, and prominent sebaceous glands 5. The condition can be challenging to diagnose in darker skin tones because telangiectasia and flushing are difficult to visualize 5.

Clinical Assessment Algorithm

Examine the location and characteristics:

  1. If darkening is at or near the infusion site:

    • Most likely cutaneous hemosiderosis from iron extravasation
    • Appears as brownish hyperpigmentation
    • May be permanent but can spontaneously resolve over 9-39 months 1
    • Treatment options include Q-switched 532 nm Nd:YAG laser 2
  2. If darkening is in the rosacea distribution but distant from infusion:

    • Consider post-inflammatory hyperpigmentation from rosacea itself
    • Evaluate for disease flare or worsening
    • Rare possibility of diffuse hemosiderosis if patient has hyperhidrosis 4
  3. If the "spot" was already darker than surrounding skin:

    • May represent normal variation in rosacea presentation in darker skin tones
    • Rosacea is difficult to diagnose in patients with darker skin because erythema and telangiectasia are less visible 5

Important Caveats

Oxidative stress connection: One older study 6 found higher ferritin levels in rosacea patients' skin and suggested iron metabolism plays a role in rosacea pathophysiology through oxidative stress. However, this does not establish that systemic iron infusions worsen rosacea lesions.

No direct causation: The provided evidence includes no cases, guidelines, or studies documenting that iron infusions cause pre-existing rosacea lesions to darken. The two conditions (iron-induced skin staining and rosacea) can coexist but are mechanistically distinct.

Management Approach

  • Document the exact location of darkening relative to the infusion site and rosacea distribution
  • Photograph the area for longitudinal comparison
  • If at infusion site: Reassure that spontaneous resolution may occur over months to years 1; laser therapy is available if desired 2
  • If in rosacea area but not infusion site: Treat the rosacea according to standard guidelines with topical agents (azelaic acid, ivermectin, metronidazole) or systemic therapy if severe 7
  • Consider dermatology referral if the presentation is atypical or if cosmetic concerns are significant

The temporal association with iron infusion may be coincidental rather than causal, particularly if the darkening is in the rosacea distribution rather than at the infusion site.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.